DGAP-DD: STADA Arzneimittel AG english



Notification concerning transactions by persons performing managerial
responsibilities pursuant to section 15a of the WpHG

Directors' Dealings notification transmitted by DGAP – a service of EQS Group
AG. 
The person with duty of notification is solely responsible for the content
of this announcement.
---------------------------------------------------------------------------

Details of the person subject to the disclosure requirement
Last name: Retzlaff
First name: Luis Paul

Relationship to a person performing managerial responsibilities: Dependent child
Details of the person performing managerial responsibilities
Position: Member of a managing body

Information about the transaction with duty of notification

Description of the financial instrument: STADA Arzneimittel AG, Registered
shares with restricted transferability and without par value 
ISIN/WKN of the financial instrument: DE0007251803
Type of transaction: Sale
Date: 24.06.2016
Price: 44.207
Currency: EUR
No. of items: 3000
Total amount traded: 132621.00
Place: Xetra

Information about the company with duty of publication

Issuer: STADA Arzneimittel AG
Stadastraße 2-18
61118 Bad Vilbel
Germany
ISIN: DE0007251803
WKN: 725180


End of Directors' Dealings Notification 
(c) DGAP 30.06.2016

DGAP Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Archive at www.dgap.de

ID 26085